Author:
Lu Xiaona,Zheng Yawei,Wen Fang,Huang Wenjie,Chen Xiaoxue,Ruan Shuai,Gu Suping,Hu Yue,Teng Yuhao,Shu Peng
Abstract
AbstractSparganii rhizoma (SL) has potential therapeutic effects on gastric cancer (GC), but its main active ingredients and possible anticancer mechanism are still unclear. In this study, we used HPLC-Q-TOF–MS/MS to comprehensively analyse the chemical components of the aqueous extract of SL. On this basis, a network pharmacology method incorporating target prediction, gene function annotation, and molecular docking was performed to analyse the identified compounds, thereby determining the main active ingredients and hub genes of SL in the treatment of GC. Finally, the mRNA and protein expression levels of the hub genes of GC patients were further analysed by the Oncomine, GEPIA, and HPA databases. A total of 41 compounds were identified from the aqueous extract of SL. Through network
analysis, we identified seven main active ingredients and ten hub genes: acacetin, sanleng acid, ferulic acid, methyl 3,6-dihydroxy-2-[(2-hydroxyphenyl) ethynyl]benzoate, caffeic acid, adenine nucleoside, azelaic acid and PIK3R1, PIK3CA, SRC, MAPK1, AKT1, HSP90AA1, HRAS, STAT3, FYN, and RHOA. The results indicated that SL might play a role in GC treatment by controlling the PI3K-Akt and other signalling pathways to regulate biological processes such as proliferation, apoptosis, migration, and angiogenesis in tumour cells. In conclusion, this study used HPLC-Q-TOF–MS/MS combined with a network pharmacology approach to provide an essential reference for identifying the chemical components of SL and its mechanism of action in the treatment of GC.
Funder
National Natural Science Foundation of China
Pilot Gastric Cancer Project of Clinical Cooperation of Traditional Chinese and Western Medicine for Major and Difficult Diseases
Project of evidence-based capacity building of traditional Chinese medicine, Chinese Academy of Traditional Chinese Medicine, State Administration of Traditional Chinese Medicine
Publisher
Springer Science and Business Media LLC
Reference75 articles.
1. Bray, F. et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 68, 394–424. https://doi.org/10.3322/caac.21492 (2018).
2. Commission, C. P. Pharmacopoeia of the People’s Republic of China, 2015 Vol. I (China Medical Science Press, Beijing, 2015).
3. Chen, Y. The Inhibitory Effect of Jianpi Yangwei Decoction and Its Decomposed Formulas on BGC823/5-Fu Cell Growth (Nanjing University of Chinese Medicine, Nanjing, 2018).
4. Ji, A., Lu, J., Liu, S., Jing, C. & Li, S. Anti-proliferation and pro-apoptosis effect of sanleng powder extract on human gastric carcinoma cell SGC-7901. Liaoning J. Traditional Chin. Med. 43, 114–117. https://doi.org/10.13192/j.issn.1000-1719.2016.01.047 (2016).
5. Cheng, L. et al. Sanling Xiaoliu mixture’s influence on the progression-free survival and quality of life of advanced gastric cancer patients. Chin. J. Integrated Traditional Western Med. Digest. 26, 636–639. https://doi.org/10.3969/j.issn.1671-038X (2018).